{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:45:01Z","timestamp":1790750701408,"version":"4.1.0"},"posted":{"date-parts":[[2024,12,5]]},"group-title":"In Review","reference-count":45,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T00:00:00Z","timestamp":1733356800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,11,20]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Objectives: <\/bold>To describe common pulmonary vasodilators (PV), exposure timing, and characteristics associated to their use in very preterm (VP) infants.\n<bold>Study Design: <\/bold>Observational study of VP infants discharged from U.S. children\u2019s hospitals (2011-2021). PV exposures during hospitalization were identified, and multivariable modeling determined characteristics associated with exposure.\n<bold>Results:<\/bold> Among 37,428 infants, 6.3% received PV. Early inhaled nitric oxide (iNO) and late sildenafil were most common. Early exposure was associated with lower gestational age, aOR: 9.2 (7.3-11.7), 22-25 vs. 29-31 weeks) and small for gestational age (SGA), 2.3 (2.0-2.7). Late exposure was associated with bronchopulmonary dysplasia (BPD) grade, 26.2 (16.8-40.9), grade 3 vs. no BPD) and early PV exposure, 3.7 (2.9-4.8).\n<bold>Conclusions:<\/bold> Early iNO and late sildenafil are used in VP infants despite limited evidence. Prospective early studies enrolling extremely preterm or SGA infants and late studies enrolling infants with early PV exposure or high-grade BPD would target current evidence gaps.<\/p>","DOI":"10.21203\/rs.3.rs-5492163\/v1","type":"posted-content","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T03:09:17Z","timestamp":1733368157000},"source":"Crossref","is-referenced-by-count":2,"title":["Pulmonary vasodilator use in very preterm infants in United States children\u2019s hospitals"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1083-6329","authenticated-orcid":false,"given":"Tomas F.","family":"Vega","sequence":"first","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Huber","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-8032","authenticated-orcid":false,"given":"Erik A.","family":"Jensen","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-5447","authenticated-orcid":false,"given":"Catherine M.","family":"Avitabile","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Lorch","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A.","family":"Gibbs","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"O'Byrne","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Children\u2019s Hospital of Philadelphia; Clinical Futures, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Frank","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-093X","authenticated-orcid":false,"given":"Nicolas A.","family":"Bamat","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Children\u2019s Hospital of Philadelphia; Clinical Futures, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","author":"Perin J","unstructured":"Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000\u201319: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet Child Adolesc Health [Internet]. 2022 Feb 1 [cited 2024 Apr 13];6(2):106\u201315. Available from: http:\/\/www.thelancet.com\/article\/S2352464221003114\/fulltext"},{"key":"ref2","author":"Stoll BJ","unstructured":"Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993\u20132012. JAMA [Internet]. 2015 Sep 8 [cited 2022 Jul 19];314(10):1039\u201351. Available from: https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2434683"},{"key":"ref3","author":"Manuck TA","year":"2016","unstructured":"Manuck TA, Rice MM, Bailit JL, Grobman WA, Reddy UM, Wapner RJ, et al. Preterm Neonatal Morbidity and Mortality by Gestational Age: A Contemporary Cohort. Am J Obstet Gynecol [Internet]. 2016 Jul 1 [cited 2024 May 18];215(1):103.e1. Available from: \/pmc\/articles\/PMC4921282\/"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41390-020-0993-4","article-title":"Pulmonary hypertension in bronchopulmonary dysplasia","volume":"89","author":"Hansmann G","year":"2021","unstructured":"Hansmann G, Sallmon H, Roehr CC, Kourembanas S, Austin ED, Koestenberger M. Pulmonary hypertension in bronchopulmonary dysplasia. Pediatr Res. 2021;89(3):446\u201355.","journal-title":"Pediatr Res"},{"key":"ref5","author":"Khemani E","unstructured":"Khemani E, McElhinney DB, Rhein L, Andradeb O, Lacro R V., Thomas KC, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics [Internet]. 2007 Dec [cited 2022 Jul 10];120(6):1260\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18055675\/"},{"key":"ref6","author":"Altit G","unstructured":"Altit G, Bhombal S, Hopper RK, Tacy TA, Feinstein J. Death or resolution: the \u201cnatural history\u201d of pulmonary hypertension in bronchopulmonary dysplasia. J Perinatol [Internet]. 2019 Mar 1 [cited 2022 Jul 13];39(3):415\u201325. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30617286\/"},{"key":"ref7","author":"Ong MS","unstructured":"Ong MS, Abman S, Austin ED, Feinstein JA, Hopper RK, Krishnan US, et al. Racial and Ethnic Differences in Pediatric Pulmonary Hypertension: An Analysis of the Pediatric Pulmonary Hypertension Network Registry. J Pediatr [Internet]. 2019 Aug 1 [cited 2022 Jul 20];211:63\u201371.e6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31176455\/"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/archdischild-2019-318531","article-title":"Fate of pulmonary hypertension associated with bronchopulmonary dysplasia beyond 36 weeks postmenstrual age","volume":"106","author":"Arjaans S","year":"2021","unstructured":"Arjaans S, Haarman MG, Roofthooft MTR, Fries MWF, Kooi EMW, Bos AF, et al. Fate of pulmonary hypertension associated with bronchopulmonary dysplasia beyond 36 weeks postmenstrual age. Arch Dis Child Fetal Neonatal Ed. 2021;106(1):45\u201350.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"2","key":"ref9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000516107","article-title":"Pulmonary Hypertension: The Hidden Danger for Newborns","volume":"118","author":"Abman SH","year":"2021","unstructured":"Abman SH. Pulmonary Hypertension: The Hidden Danger for Newborns. Neonatology. 2021;118(2):211\u20137.","journal-title":"Neonatology"},{"key":"ref10","author":"Malloy KW","year":"2021","unstructured":"Malloy KW, Austin ED. Pulmonary hypertension in the child with bronchopulmonary dysplasia. Pediatr Pulmonol [Internet]. 2021 Nov 1 [cited 2022 Jul 13];56(11):3546\u201356. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34324276\/"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jpeds.2018.07.035","article-title":"The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year","volume":"203","author":"Lagatta JM","year":"2018","unstructured":"Lagatta JM, Hysinger EB, Zaniletti I, Wymore EM, Vyas-Read S, Yallapragada S, et al. The Impact of Pulmonary Hypertension in Preterm Infants with Severe Bronchopulmonary Dysplasia through 1 Year. Journal of Pediatrics. 2018;203:218\u2013224.e3.","journal-title":"Journal of Pediatrics"},{"key":"ref12","author":"Swier NL","year":"2016","unstructured":"Swier NL, Richards B, Cua CL, Lynch SK, Yin H, Nelin LD, et al. Pulmonary Vein Stenosis in Neonates with Severe Bronchopulmonary Dysplasia. Am J Perinatol [Internet]. 2016 Jun 1 [cited 2022 Jul 19];33(7):671\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26862723\/"},{"issue":"21","key":"ref13","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1161\/CIR.0000000000000329","article-title":"Pediatric pulmonary hypertension","volume":"132","author":"Abman SH","year":"2015","unstructured":"Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, et al. Pediatric pulmonary hypertension. Circulation. 2015;132(21):2037\u201399.","journal-title":"Circulation"},{"issue":"9","key":"ref14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","article-title":"2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT","volume":"38","author":"Hansmann G","year":"2019","unstructured":"Hansmann G, Koestenberger M, Alastalo TP, Apitz C, Austin ED, Bonnet D, et al. 2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: The European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT. Journal of Heart and Lung Transplantation. 2019;38(9):879\u2013901.","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"ref15","author":"Abman SH","year":"2021","unstructured":"Abman SH, Mullen MP, Sleeper LA, Austin ED, Rosenzweig EB, Kinsella JP, et al. Characterisation of paediatric pulmonary hypertensive vascular disease from the PPHNet Registry. Eur Respir J [Internet]. 2021 Jan 1 [cited 2022 Jun 30];59(1). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34140292\/"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2017.05.029","article-title":"Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia","volume":"188","author":"Krishnan U","year":"2017","unstructured":"Krishnan U, Feinstein JA, Adatia I, Austin ED, Mullen MP, Hopper RK, et al. Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary Dysplasia. Journal of Pediatrics. 2017;188:24\u201334.e1.","journal-title":"Journal of Pediatrics"},{"key":"ref17","author":"Collaco JM","unstructured":"Collaco JM, Abman SH, Austin ED, Avitabile CM, Bates A, Fineman JR, et al. Kids Mod PAH trial: A multicenter trial comparing mono- versus duo\u2010therapy for initial treatment of pediatric pulmonary hypertension. Pulm Circ [Internet]. 2023 Oct 1 [cited 2024 Feb 17];13(4). Available from: \/pmc\/articles\/PMC10617301\/"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpeds.2016.10.082","article-title":"Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia","volume":"181","author":"Abman SH","year":"2017","unstructured":"Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. Journal of Pediatrics. 2017;181:12\u201328.e1.","journal-title":"Journal of Pediatrics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jpeds.2017.11.027","article-title":"Hospital Readmissions in Children with Pulmonary Hypertension: A Multi-Institutional Analysis","volume":"195","author":"Awerbach JD","year":"2018","unstructured":"Awerbach JD, Mallory GB, Kim S, Cabrera AG. Hospital Readmissions in Children with Pulmonary Hypertension: A Multi-Institutional Analysis. Journal of Pediatrics. 2018;195:95\u2013101.e4.","journal-title":"Journal of Pediatrics"},{"key":"ref20","author":"Bamat NA","unstructured":"Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon MM, Zhang H, et al. Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children\u2019s hospitals. Journal of Perinatology 2019 39:9 [Internet]. 2019 Jun 21 [cited 2024 Feb 15];39(9):1291\u20139. Available from: https:\/\/www.nature.com\/articles\/s41372-019-0415-9"},{"key":"ref21","author":"Bamat NA","unstructured":"Bamat NA, Nelin TD, Eichenwald EC, Kirpalani H, Laughon MM, Jackson WM, et al. Loop Diuretics in Severe Bronchopulmonary Dysplasia: Cumulative Use and Associations with Mortality and Age at Discharge. J Pediatr [Internet]. 2021 Apr 1 [cited 2022 Sep 27];231:43\u201349.e3. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/33152371\/"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1542\/hpeds.2015-0076","article-title":"Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension","volume":"6","author":"Backes CH","year":"2016","unstructured":"Backes CH, Reagan PB, Smith C V., Jadcherla SR, Slaughter JL. Sildenafil Treatment of Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. Hosp Pediatr. 2016;6(1):27\u201333.","journal-title":"Hosp Pediatr"},{"key":"ref23","doi-asserted-by":"publisher","author":"Greenberg JM","unstructured":"Greenberg JM, Poindexter BB, Shaw PA, Bellamy SL, Keller RL, Moore PE, et al. Respiratory medication use in extremely premature (<\u200929 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program. Pediatr Pulmonol [Internet]. 2020 Feb 1 [cited 2022 Jun 7];55(2):360\u20138. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/ppul.24592","DOI":"10.1002\/ppul.24592"},{"key":"ref24","author":"Stenger MR","unstructured":"Stenger MR, Slaughter JL, Kelleher K, Shepherd EG, Klebanoff MA, Reagan P, et al. Hospital variation in nitric oxide use for premature infants. Pediatrics [Internet]. 2012 Apr [cited 2022 Jun 5];129(4):e945-51. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22412028"},{"key":"ref25","author":"Laas E","year":"2012","unstructured":"Laas E, Lelong N, Thieulin AC, Houyel L, Bonnet D, Ancel PY, et al. Preterm birth and congenital heart defects: a population-based study. Pediatrics [Internet]. 2012 Oct [cited 2023 Nov 27];130(4). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22945415\/"},{"issue":"6","key":"ref26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","article-title":"The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants An Evidence-based Approach","volume":"200","author":"Jensen EA","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants An Evidence-based Approach. Am J Respir Crit Care Med. 2019;200(6):751\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-13-59","author":"Fenton TR","year":"2013","unstructured":"Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr [Internet]. 2013 Apr 20 [cited 2022 Sep 13];13(1):1\u201313. Available from: https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/1471-2431-13-59"},{"key":"ref28","author":"Baum CF","year":"2008","unstructured":"Baum CF. Stata tip 63: Modeling proportions [Internet]. Vol. 8, The Stata Journal. 2008. Available from: http:\/\/www.stata-press.com\/data\/r10\/census7"},{"key":"ref29","author":"Humpl T","unstructured":"Humpl T, Reyes JT, Erickson S, Armano R, Holtby H, Adatia I. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease. Cardiol Young [Internet]. 2011 Apr [cited 2022 Jul 19];21(2):187\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21138617\/"},{"key":"ref30","author":"Mourani PM","unstructured":"Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr [Internet]. 2009 [cited 2022 Jul 19];154(3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/18950791\/"},{"key":"ref31","author":"Wardle AJ","unstructured":"Wardle AJ, Wardle R, Luyt K, Tulloh R. The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia. Arch Dis Child [Internet]. 2013 Aug [cited 2022 Jul 19];98(8):613\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/23625986\/"},{"key":"ref32","author":"Baquero H","unstructured":"Baquero H, Soliz A, Neira F, Venegas ME, Sola A. Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics [Internet]. 2006 [cited 2022 Jul 19];117(4):1077\u201383. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16585301\/"},{"key":"ref33","doi-asserted-by":"publisher","author":"Schneider S","unstructured":"Schneider S, Bailey M, Spears T, Esther CR, Laughon MM, Hornik CP, et al. Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study. BMC Pediatr [Internet]. 2020 Dec 1 [cited 2022 Jul 17];20(1):1\u20139. Available from: https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-020-02453-7","DOI":"10.1186\/s12887-020-02453-7"},{"key":"ref34","author":"Lang JE","unstructured":"Lang JE, Hornik CD, Martz K, Jacangelo J, Anand R, Greenberg R, et al. Safety of sildenafil in premature infants at risk of bronchopulmonary dysplasia: Rationale and methods of a phase II randomized trial. Contemp Clin Trials Commun [Internet]. 2022 Dec 1 [cited 2024 Feb 17];30. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36345347\/"},{"key":"ref35","author":"Hasan SU","unstructured":"Hasan SU, Potenziano J, Konduri GG, Perez JA, Van Meurs KP, Walker MW, et al. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr [Internet]. 2017 Nov 1 [cited 2023 Nov 26];171(11):1081\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/28973344\/"},{"key":"ref36","author":"Barrington KJ","year":"2017","unstructured":"Barrington KJ, Finer N, Pennaforte T. Inhaled nitric oxide for respiratory failure in preterm infants. Vol. 2017, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2017."},{"key":"ref37","author":"Thompson EJ","year":"2019","unstructured":"Thompson EJ, Perez K, Hornik CP, Smith PB, Clark RH, Laughon M. Sildenafil Exposure in the Neonatal Intensive Care Unit. Am J Perinatol [Internet]. 2019 [cited 2024 Apr 18];36(3):262. Available from: \/pmc\/articles\/PMC6996478\/"},{"key":"ref38","doi-asserted-by":"publisher","author":"Barrington KJ","unstructured":"Barrington KJ, Finer N, Pennaforte T, Altit G. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database of Systematic Reviews [Internet]. 2017 Jan 5 [cited 2024 Apr 18];2017(1). Available from: https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD000399.pub3\/full","DOI":"10.1002\/14651858.CD000399.pub3\/full"},{"key":"ref39","author":"Graaf M","year":"2019","unstructured":"van der Graaf M, Rojer LA, Helbing WA, Reiss IKM, Etnel JRG, Bartelds B. Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. Pulm Circ [Internet]. 2019 Jul 1 [cited 2024 Feb 17];9(3). Available from: \/pmc\/articles\/PMC6681505\/"},{"key":"ref40","author":"Jackson W","unstructured":"Jackson W, Gonzalez D, Smith PB, Ambalavanan N, Atz AM, Sokol GM, et al. Safety of sildenafil in extremely premature infants: a phase I trial. Journal of Perinatology 2021 42:1 [Internet]. 2021 Nov 5 [cited 2024 Jan 28];42(1):31\u20136. Available from: https:\/\/www.nature.com\/articles\/s41372-021-01261-w"},{"key":"ref41","author":"Mourani PM","unstructured":"Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, et al. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med [Internet]. 2015 Jan 1 [cited 2022 Jun 26];191(1):87\u201395. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/25389562\/"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpeds.2022.07.039","article-title":"Clinical Significance of Early Pulmonary Hypertension in Preterm Infants","volume":"251","author":"Arjaans S","year":"2022","unstructured":"Arjaans S, Fries MWF, Schoots MH, Schilte CFM, Roofthooft MTR, Vrijlandt EJLE, et al. Clinical Significance of Early Pulmonary Hypertension in Preterm Infants. J Pediatr. 2022;251:74\u201381.e3.","journal-title":"J Pediatr"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.2663","author":"Lewis TR","year":"2022","unstructured":"Lewis TR, Kielt MJ, Walker VP, Levin JC, Guaman MC, Panitch HB, et al. Association of Racial Disparities With In-Hospital Outcomes in Severe Bronchopulmonary Dysplasia. JAMA Pediatr [Internet]. 2022;176(9):852\u20139. Available from: https:\/\/doi.org\/10.1001\/jamapediatrics.2022.2663"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.025784","author":"Backes CH","year":"2022","unstructured":"Backes CH, Hill KD, Shelton EL, Slaughter JL, Lewis TR, Weisz DE, et al. Patent Ductus Arteriosus: A Contemporary Perspective for the Pediatric and Adult Cardiac Care Provider. J Am Heart Assoc [Internet]. 2022;11(17):e025784. Available from: https:\/\/doi.org\/10.1161\/JAHA.122.025784"},{"key":"ref45","author":"Supplementary","unstructured":"Supplementary Figure Legends"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5492163\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5492163\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T07:08:25Z","timestamp":1746256105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-5492163\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,5]]},"references-count":45,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-5492163\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1038\/s41372-025-02309-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,12,5]]},"subtype":"preprint"}}